Clinical acute lung injury and acute respiratory distress syndrome

Current Treatment Options in Cardiovascular Medicine

Volumn 4, Issue 2, 2002, Pages 139-149

  Matthay, Michael A ^a   Uchida, Tokujiro ^a   Fang, Xiaohui ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute Lung Injury; Acute Respiratory Distress Syndrome; Adult Respiratory Distress Syndrome; Lung Injury; Respir Crit

Indexed keywords

EID: 0038507600     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-002-0034-0     Document Type: Article

References (69)

1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000, 342:1334–1349. An excellent recent review of the epidemiology, definitions, pathogenesis, and treatment of ARDS.
2. Doyle RL, Szaflarski N, Modin GW, et al.: Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995, 152:1818–1824.
3. Zilberberg MD, Epstein SK: Acute lung injury in the medical ICU. Comorbid conditions, age, etiology and hospital outcome. Am J Respir Crit Care Med 1998, 157:1159–1164.
4. Murray JF, Matthay MA, Luce JM, et al.: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988, 138:720–723.
5. Eisner M, Thompson T, Hudson L, et al.: Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 164:231–236. A recent original article providing evidence that the protective lung ventilation strategy is efficacious in all clinical disorders associated with clinical ALI.
6. Montgomery AB, Stager MA, Carrico CJ, et al.: Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985, 132:485–489.
7. Bernard GR, Artigas A, Brigham KL, et al.: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818–824.
8. Eberhard L, Morabito D, Matthay M, et al.: Initial severity of metabolic acidosis predicts the development of acute lung injury in severely traumatized patients. Crit Care Med 2000, 28:125–131.
9. Ashbaugh DG, Bigelow DB, Petty TL, et al.: Acute respiratory distress in adults. Lancet 1967, 2:319–323.
10. Nuckton T, Alonso J, Kallet R, et al.: In early ARDS wasted ventilation predicts mortality. Am J Resp Crit Care Med 2001, 163:A450.
11. Matthay MA, Broaddus VC: Fluid and hemodynamic management in acute lung injury. Sem Resp Med 1994, 15:271–288.
12. Fowler AA, Hamman RF, Good JT, et al.: Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 1983, 98:593–597.
13. Pepe PE, Potkin RT, Reus DH, et al.: Clinical predictors of the adult respiratory distress syndrome. Am J Surg 1982, 144:124–130.
14. Ware LB, Conner E, Matthay MA: Von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med 2001, 29:2325–2331.
15. Anderson WR, Thielen K: Correlative study of adult respiratory distress syndrome by light, scanning, and transmission electron microscopy. Ultrastructural Pathol 1992, 16:615–628.
16. Bachofen M, Weibel ER: Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis 1977, 116:589–615.
17. Tomashefski JF: Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 2000, 21:435–466.
18. Wiener-Kronish JP, Albertine KH, Matthay MA: Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest 1991, 88:864–875.
19. Ware LB, Matthay MA: Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Resp Crit Care Med 2001, 163:1376–1383. A recent original publication demonstrating that the rate of alveolar edema fluid clearance when maximal is associated with better clinical outcomes.
20. Matthay MA, Wiener-Kronish JP: Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990, 142:1250–1257.
21. Gregory TJ, Longmore WJ, Moxley MA, et al.: Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991, 88:1976–1981.
22. Kurahashi K, Kajikawa O, Sawa T, et al.: Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest 1999, 104:743–750.
23. Bitterman PB: Pathogenesis of fibrosis in acute lung injury. Am J Med 1992, 92:39S-43S.
24. Pittet JF, MacKersie RC, Martin TR, et al.: Biochemical markers of acute lung injury: prognostic and pathogenetic significance. Am J Resp Crit Care Med 1997, 155:1187–1205.
25. Matthay MA: Conference summary: acute lung injury. Chest 1999, 116:119S-126S.
26. Laufe MD, Simon RH, Flint A, et al.: Adult respiratory distress syndrome in neutropenic patients. Am J Med 1986, 80:1022–1026.
27. Nelson S, Belknap SM, Carlson RW, et al.: A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group. J Infect Dis 1998, 178:1075–1080.
28. Folkesson HG, Matthay MA, Herbert CA, et al.: Acid aspiration induced lung injury in rabbits is mediated by interleukin-8 dependent mechanisms. J Clin Invest 1995, 96:107–116.
29. Pugin J, Verghese G, Widmer M-C, et al.: The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of ARDS. Crit Care Med 1999, 27:304–312.
30. Webb HH, Tierney DF: Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures. Protection by positive end expiratory pressure. Am Rev Respir Dis 1974, 110:556–565.
31. Dreyfuss D, Soler P, Basset G, et al.: High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988, 137:1159–1164.
32. Parker JC, Townsley MI, Rippe B, et al.: Increased microvascular permeability in dog lungs due to high peak airway pressure. J Appl Physiol 1984, 57:1809–1816.
33. Slutsky AS, Tremblay LN: Multiple system organ failure: is mechanical ventilation a contributing factor. Am J Respir Crit Care Med 1998, 157:1721–1725.
34. ARDS Network: Ventilation with low tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301–1308. The original publication demonstrating in a phase III design that low tidal volume ventilation with a plateau pressure limit reduced mortality substantially in patients with ALI/ARDS.
35. Bernard GR, Vincent J-L, Laterre P-F, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699–709. A recent article demonstrating that recombinant human activated protein C reduces mortality in patients with severe sepsis.
36. Matthay MA: Severe sepsis—a new treatment with both anticoagulant and antiinflammatory properties. N Engl J Med 2001, 344:759–762.
37. Ware LB, Golden JA, Finkbeiner WE, et al.: Alveolar epithelial fluid transport capacity in reperfusion lung injury after lung transplantation. Am J Respir Crit Care Med 1999, 159:980–988.
38. Fukuda Y, Ishizaki M, Masuda Y, et al.: The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol 1987, 126:171–182.
39. Martin C, Papazian L, Payan MJ, et al.: Pulmonary fibrosis correlates with outcome in the adult respiratory distress syndrome. Chest 1995, 107:196–200.
40. Chesnutt AN, Matthay MA, Tibayan FA, et al.: Early detection of type III procollagen peptide in acute lung injury. Am J Respir Crit Care Med 1997, 156:840–845.
41. Clark JG, Milberg JA, Steinberg KP, et al.: Type III procollagen peptide in the adult respiratory distress syndrome. Ann Intern Med 1995, 122:17–23.
42. Matthay MA, Folkesson HG, Verkman AS: Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol 1996, 270:L487-L503.
43. Milberg JA, Davis DR, Steinberg KP, et al.: Improved survival of patients with acute respiratory distress syndrome (ARDS):1983-1993. JAMA 1995, 273:306–309.
44. Heyland DK, Cook DJ, Guyatt GH: Enteral nutrition in the critically ill patients: a critical review of the evidence. Intens Care Med 1993, 19:435–442.
45. Saint S, Matthay MA: Risk reduction in the intensive care unit. Am J Med 1998, 105:515–523.
46. Brower RC, Ware LB, Berthiame Y, et al.: Treatment of the acute respiratory distress syndrome. Chest 2001, 120:1347–1367.
47. Zapol WM, Snider MT, Hill JD, et al.: Extracorporeal membrane oxygenation in severe acute respiratory failure. JAMA 1979, 242:2193–2196.
48. Morris AH, Wallace CJ, Menlove RL, et al.: Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994, 149:295–305.
49. Falke KH, Pontoppidan H, Kumar A: Ventilation with end-expiratory pressure in acute lung disease. J Clin Invest 1972, 51:2315–2323.
50. Gattinoni L, Pesenti A, Bombino M: Relationship between lung computed tomographic density, gas exchange, and PEEP in acute respiratory failure. Anesthesiology 1988, 69:824–832.
51. Pepe PE, Hudson LD, Carrico CJ: Early application of positive end-expiratory pressure in patients at risk for the adult respiratory distress syndrome. N Engl J Med 1984, 311:281–286.
52. Amato MB, Barbas CS, Medeiros DM, et al.: Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998, 338:347–354.
53. Gattinoni L, Tognoni G, Pesenti A, et al.: Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2001, 345:568–573.
54. Prewitt RM, McCarthy J, Wood LDH: Treatment of acute low pressure pulmonary edema in dogs. J Clin Invest 1981, 67:409–418.
55. Simmons RS, Berdine GG, Seidenfeld JJ, et al.: Fluid balance and the adult respiratory distress syndrome. Am Rev Respir Dis 1987, 135:924–929.
56. Hayes MA, Timmins AC, Yau EHS, et al.: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994, 330:1717–1722.
57. Long W, Thompson T, Sundell H, et al.: Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700-to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I. J Pediatr 1991, 118:595–605.
58. Anzuetto A, Baughman RP, Guntupalli KK, et al.: Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996, 334:1417–1421.
59. Rossaint R, Falke KJ, Lopez F, et al.: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993, 328:399–405.
60. Dellinger RP, Zimmerman JL, Taylor RW: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med 1998, 26:15–23.
61. Payen D, Vallet B, and the Genoa Group: Results of the French prospective multicenter randomized double-blind placebo-controlled trial on inhaled nitric oxide in ARDS. Intens Care Med 1999, 25:S166.
62. Meduri GU, Headley AS, Golden E, et al.: Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998, 280:159–165.
63. Frank JA, Wang Y, Osorio O, et al.: Beta-adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats. J Appl Physiol 2000, 89:1255–1265.
64. Lasnier JM, Wangensteen OD, Schmitz LS, et al.: Terbutaline stimulates alveolar fluid resorption in hyperoxic lung injury. J Appl Physiol 1996, 81:1783–1789.
65. Garat C, Meignan M, Matthay MA, et al.: Alveolar epithelial fluid clearance mechanisms are intact after moderate hyperoxic lung injury in rats. Chest 1997, 111:1381–1388.
66. Wright PE, Carmichael LC, Bernard GR: Effect of bronchodilators on lung mechanics in the acute respiratory distress syndrome (ARDS). Chest 1994, 106:1517–1523.
67. Atabai K, Ware L, Snider M, et al.: Aerosolized beta-2 agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients. Am J Resp Crit Care Med 2001, 163:A618.
68. Panos RJ, Bak PM, Simone WS, et al.: Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J Clin Invest 1995, 96:2026–2033.
69. Oswari J, Matthay MA, Margulies SS: Keratinocyte growth factor reduces alveolar epithelial susceptibility to in vitro mechanical deformation. Am J Physiol Lung Cell Mol Physiol 2001, 281:L1068–1077.